We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

Parkinson's Disease Study


Protocol Title:

An Open-Label, Phase 2 Study to Assess the Safety and Efficacy of 99mTc-NC100697 Injection in Detecting or Excluding Striatal Dopaminergic Deficits in Subjects With 1 or More Signs of a Parkinsonian Syndrome

Principal Investigator:

Alan Waxman, MD

IRB Approval Number:


Medical Specialty Area:



Patients with tremor and suspected Parkinson's Disease

IRB Approval Expiration Date:

5/31/07 (continuation has been submitted)

The study is ongoing, and patients are undergoing follow up, but enrollment to new subjects is closed.

Contact Information:

Jessica Lee (Study Coordinator)
Phone: (310) 423-7546
Send Us a Message